Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haluska

Showing results (361-370 of 366) with videos related to

Pageof 37
Sort By:
You have reached the last page of results.This site can display upto 366 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2015
The Neoadjuvant Model Is Still the Future for Drug Development in Breast CancerAngela DeMichele, Douglas Yee, Donald A Berry, et al.
Nature|May 8, 2024
Computationally restoring the potency of a clinical antibody against OmicronThomas A Desautels, Kathryn T Arrildt, Adam T Zemla, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2022
Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariantsThomas A Desautels, Kathryn T Arrildt, Adam T Zemla, et al.
NPJ Breast Cancer|October 6, 2021
Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancerDouglas Yee, Claudine Isaacs, Denise M Wolf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2020
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)Aline Talhouk, Joshy George, Chen Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2020
Prognostic gene expression signature for high-grade serous ovarian cancerJ Millstein, T Budden, E L Goode, et al.
Pageof 37

Showing results (361-370 of 366) with videos related to

Sort By:
Pageof 37
You have reached the last page of results.This site can display upto 366 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2015
The Neoadjuvant Model Is Still the Future for Drug Development in Breast CancerAngela DeMichele, Douglas Yee, Donald A Berry, et al.
Nature|May 8, 2024
Computationally restoring the potency of a clinical antibody against OmicronThomas A Desautels, Kathryn T Arrildt, Adam T Zemla, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2022
Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariantsThomas A Desautels, Kathryn T Arrildt, Adam T Zemla, et al.
NPJ Breast Cancer|October 6, 2021
Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancerDouglas Yee, Claudine Isaacs, Denise M Wolf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2020
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)Aline Talhouk, Joshy George, Chen Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2020
Prognostic gene expression signature for high-grade serous ovarian cancerJ Millstein, T Budden, E L Goode, et al.
Pageof 37